Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Phase 1: To establish the recommended Phase 2 dose for JNJ-40346527. Phase 2: To determine the overall response rate (complete response [CR] + partial response [PR]) in subjects with relapsed or refractory cHL.
Inclusion criteria
- Subjects with Relapsed or Refractory Hodgkin’s Lymphoma